全文获取类型
收费全文 | 3070篇 |
免费 | 355篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 83篇 |
妇产科学 | 100篇 |
基础医学 | 512篇 |
口腔科学 | 69篇 |
临床医学 | 410篇 |
内科学 | 570篇 |
皮肤病学 | 51篇 |
神经病学 | 194篇 |
特种医学 | 213篇 |
外科学 | 422篇 |
综合类 | 58篇 |
预防医学 | 209篇 |
眼科学 | 46篇 |
药学 | 274篇 |
中国医学 | 6篇 |
肿瘤学 | 208篇 |
出版年
2021年 | 44篇 |
2020年 | 19篇 |
2019年 | 41篇 |
2018年 | 54篇 |
2017年 | 26篇 |
2016年 | 36篇 |
2015年 | 57篇 |
2014年 | 88篇 |
2013年 | 95篇 |
2012年 | 100篇 |
2011年 | 149篇 |
2010年 | 69篇 |
2009年 | 75篇 |
2008年 | 138篇 |
2007年 | 116篇 |
2006年 | 120篇 |
2005年 | 139篇 |
2004年 | 120篇 |
2003年 | 119篇 |
2002年 | 98篇 |
2001年 | 94篇 |
2000年 | 97篇 |
1999年 | 107篇 |
1998年 | 59篇 |
1997年 | 45篇 |
1996年 | 56篇 |
1995年 | 64篇 |
1994年 | 37篇 |
1993年 | 36篇 |
1992年 | 71篇 |
1991年 | 80篇 |
1990年 | 70篇 |
1989年 | 76篇 |
1988年 | 87篇 |
1987年 | 73篇 |
1986年 | 64篇 |
1985年 | 69篇 |
1984年 | 58篇 |
1983年 | 43篇 |
1982年 | 36篇 |
1981年 | 24篇 |
1980年 | 27篇 |
1979年 | 41篇 |
1978年 | 23篇 |
1977年 | 20篇 |
1976年 | 26篇 |
1975年 | 22篇 |
1974年 | 19篇 |
1972年 | 22篇 |
1971年 | 20篇 |
排序方式: 共有3443条查询结果,搜索用时 0 毫秒
61.
Jiao Peng Julia Y. Tsang Derek H. Ho Ruizhong Zhang Haitao Xiao Daxu Li Jiang Zhu Fenghua Wang Zhaoxiang Bian Vincent C. Lui Aimin Xu Paul K. Tam Jonathan R. Lamb Huimin Xia Yan Chen 《International journal of cancer. Journal international du cancer》2015,137(4):848-858
The plasticity of macrophages with selective functional phenotypes partially arises in respective to their microenvironment. Tumor‐associated macrophages (TAMs) may promote disease progression with tumor specific manner. Here we report that in pediatric malignant soft‐tissue tumors, the presence of TAMs and expression of adiponectin (APN) are heterogeneous. Both APN and TAMs had high expression in rhabdomyosarcoma, especially in the malignant subtype, alveolar rhabdomyosarcoma. To investigate the mode of action of APN on TAM activation, a murine MN/MCA1 sarcoma model was used. The Results revealed that exogenous APN had no effect on MN/MCA1 proliferation but tumor size was markedly reduced in apn?/? mice versus WT controls. The accumulation of TAMs in apn?/? mice was also reduced which correlated to downregulated serum levels of MCP‐1. Likewise, TAMs in apn?/? mice exhibited a M1‐like phenotype, characterized by increase in MHC IIhigh population and M1 phenotypic markers, such as iNOS gene and serum TNF‐α accompanied by a decrease in M2 markers, namely YM1 gene and serum IL‐10. In addition, APN deficiency increased the number of CD4+ T cells, CD8+ T cells and NK cells in tumors and reduced tumor metastasis. The altered phenotype of TAMs in apn?/? mice was associated with a marked decrease in phospho‐p38 and treatment with a p38 MAPK inhibitor significantly reduced tumor size and increased MHC II expression on TAMs in WT mice, implying p38 MAPK signaling pathway may contribute to APN‐mediated TAM polarization. Collectively, our findings suggest that APN may have a potential role in regulating soft tissue sarcoma growth. 相似文献
62.
High-throughput screening of a plant and marine invertebrate extract library to find natural products with rat thyrotropin releasing hormorne (TRH) receptor 2 binding affinity led to the isolation of four new (1-4) and one known (5) spongian diterpene from the sponge Spongia sp. The structures were assigned from interpretation of 2D NMR and high-resolution ESIMS data. The absolute configurations of 1-4 were proposed on the basis of analysis of their CD spectra. Diterpenes 1-5 showed rat TRH receptor 2 binding affinity with IC(50) values of 23 microM, 70 microM, 400 microM, 600 microM, and 1 mM, respectively. 相似文献
63.
64.
65.
Feasibility of assessment of coronary stent patency using 16-slice computed tomography 总被引:27,自引:0,他引:27
Schuijf JD Bax JJ Jukema JW Lamb HJ Warda HM Vliegen HW de Roos A van der Wall EE 《The American journal of cardiology》2004,94(4):427-430
Intracoronary stent implantation is a frequently performed procedure in the treatment of stenoses in coronary arteries, but in-stent restenosis occurs in approximately 10% to 15% of patients. A noninvasive diagnostic procedure to evaluate in-stent restenosis would therefore be of great benefit. We investigated the feasibility of assessing stent patency with 16-slice computed tomography. Multislice computed tomography (MSCT) was performed in 22 patients with previously implanted stents. For each stent, assessability was determined and related to stent type and diameter. Subsequently, the presence of significant restenosis was determined in the evaluable stents. In addition, peristent lumina (5 mm proximal and distal to the stent) were evaluated. Conventional angiography in combination with quantitative coronary angiography served as the standard of reference. MSCT was performed successfully in all but 1 patient. Of 65 stents, 50 (77%) were determined assessable. Uninterpretable stents tended to have a thicker strut and/or a smaller diameter. In the evaluable stents, 7 of 9 stenoses were detected and the absence of restenosis was correctly identified in all 41 patent stents, resulting in a sensitivity and specificity of 78% and 100%, respectively. Sensitivity and specificity for the detection of peristent stenosis were 75% and 96%, respectively. In conclusion, MSCT may be useful in the assessment of stent patency and may function as a gatekeeper before invasive diagnostic procedures. 相似文献
66.
H M Siragy N E Lamb J F Woodson N V Ragsdale C E Rose M J Peach R M Carey 《Endocrinology》1987,120(4):1272-1278
Local formation of angiotensin II (AII) within the kidney has been demonstrated. Changes in renal function induced by inhibitors of the renin-angiotensin system have been the basis for the postulate that AII may act as a paracrine substance in the kidney. We studied the renal action of chronic intrarenal infusions of AII at doses between 2 and 2000 fmol/kg X min in uninephrectomized conscious dogs monitored on 80 meq daily sodium intake. Exogenous AII was confined to the kidney, as demonstrated by the absence of systemic pressor and adrenal cortical responses during the intrarenal infusion. After 2 control days, each dose of AII was infused intrarenally for a period of 3 days. The smallest intrarenal dose of AII that caused significant antinatriuresis and antidiuresis was 20 fmol/kg X min. A significant reduction in urinary volume and sodium excretion occurred during the first 24 h of the infusion period and was proportionate to the amount of peptide infused. Renal escape from the antinatriuretic and antidiuretic effects of the peptide ensued on the second and third days of infusion. There were no significant changes in urinary potassium excretion, plasma renin activity (PRA), plasma aldosterone concentration, or blood pressure throughout the period of intrarenal AII administration. These data demonstrate dose-dependent direct antinatriuretic and antidiuretic actions of low AII concentrations. Escape from the sodium-retaining action of intrarenal AII occurred by 48 h and was independent of suppression of endogenous renin-angiotensin. These results indicate that AII alters renal function by direct intrarenal mechanisms. 相似文献
67.
Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general population 下载免费PDF全文
I. A. Dekkers R. de Mutsert A. P. J. de Vries F. R. Rosendaal S. C. Cannegieter J. W. Jukema S. le Cessie T. J. Rabelink H. J. Lamb W. M. Lijfering 《Journal of thrombosis and haemostasis》2018,16(3):519-528
Essentials
- Why venous thrombosis is more prevalent in chronic kidney disease is unclear.
- We investigated whether renal and vascular function are associated with hypercoagulability.
- Coagulation factors showed a procoagulant shift with impaired renal and vascular function.
- This suggests that renal and vascular function play a role in the etiology of thrombosis.
Summary
Background
Impaired renal and vascular function have been associated with venous thrombosis, but the mechanism is unclear.Objectives
We investigated whether estimated glomerular filtration rate (eGFR), urinary albumin‐creatinine ratio (UACR), and pulse wave velocity (PWV) are associated with a procoagulant state.Methods
In this cross‐sectional analysis of the NEO Study, eGFR, UACR, fibrinogen, and coagulation factors (F)VIII, FIX and FXI were determined in all participants (n = 6536), and PWV was assessed in a random subset (n = 2433). eGFR, UACR and PWV were analyzed continuously and per percentile: per six categories for eGFR (> 50th [reference] to < 1st) and UACR (< 50th [reference] to > 99th), and per four categories (< 50th [reference] to > 95th percentile) for PWV. Linear regression was used and adjusted for age, sex, total body fat, smoking, education, ethnicity, total cholesterol, C‐reactive protein (CRP) and vitamin K antagonists use (FIX).Results
Mean age was 55.6 years, mean eGFR 86.0 (12SD) mL 1.73 m?² and median UACR 0.4 mg mmol?1 (25th, 75th percentile; 0.3, 0.7). All coagulation factors showed a procoagulant shift with lower renal function and albuminuria. For example, FVIII was 22 IU dL?1 (95% CI, 13–32) higher in the eGFR < 1st percentile compared with the > 50th percentile, and FVIII was 12 IU dL?1 (95% CI, 3–22) higher in the UACR > 99th percentile compared with the < 50th percentile. PWV was positively associated with coagulation factors FIX and FXI in continuous analysis; per m/s difference in PWV, FIX was 2.0 IU dL?1 (95% CI, 0.70–3.2) higher.Conclusions
Impaired renal and vascular function was associated with higher levels of coagulation factors, underlining the role of renal function and vascular function in the development of venous thrombosis.68.
Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist 总被引:2,自引:0,他引:2
Erickson-Miller CL DeLorme E Tian SS Hopson CB Stark K Giampa L Valoret EI Duffy KJ Luengo JL Rosen J Miller SG Dillon SB Lamb P 《Experimental hematology》2005,33(1):85-93
OBJECTIVE: Peptide and other small molecule agonists have been described for several cytokines and growth factors. Hydrazone compounds described here as thrombopoietin receptor agonists were identified as activating STAT proteins in a Tpo responsive cell line. METHODS: STAT activation and analysis of signal transduction pathways in cell lines and normal human platelets was elucidated by Western blot and electrophoretic mobility shift assays. Proliferation assays in cell types responsive to other cytokines determined specificity for Tpo receptor. Flow cytometry quantified differentiation of CD34(+) cells into CD41(+) megakaryocytes and platelet production in vitro. RESULTS: Activation of STAT5, mitogen-activated protein kinase, p38, and early response genes by SB 394725 was similar to that induced by Tpo. SB 394725 induced a reporter gene response under a STAT activation promoter as well as the megakaryocyte-specific gpIIb promoter. The compound induced proliferation of Tpo responsive lines but demonstrated no activity in cell lines responding to other cytokines, i.e., erythropoietin, granulocyte-colony stimulating factor, interleukin-3, interferon-gamma. The response of normal human Tpo receptors was elucidated by measuring growth and differentiation of human bone marrow in vitro. Activation of endogenous Tpo receptors by SB 394725 was demonstrated in human and chimp platelets, but not in platelets of other species including mouse, dog, rabbit, or cynomolgus monkey. CONCLUSIONS: SB 394725, a small molecule with a molecular weight of 452 Da, is capable of activating Tpo-specific signal transduction, proliferation, and differentiation responses similar to the responses and functions of the protein growth factor, Tpo. 相似文献
69.
70.